Market Cap (In USD)
75.58 Thousand
Revenue (In USD)
131.31 Million
Net Income (In USD)
52.15 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.004-0.004
- PE
- -
- EPS
- -
- Beta Value
- 0.896
- ISIN
- US53220K1815
- CUSIP
- 53220K181
- CIK
- 886163
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mr. Todd C. Davis Ph.D.
- Employee Count
- -
- Website
- http://www.ligand.com
- Ipo Date
- Details
- Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
More Stocks
-
ZAIRF
-
AHELFAuscan Resources Inc.
AHELF
-
ACNI
-
BIMT
-
GGCPFGeneric Gold Corp.
GGCPF
-
BKRP
-
601212
-
POD